COLO 858 | Vemurafenib | 1 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 223.3 | 2 | 0076-0387 | 356.28 | 387.46 | 294 | 66.43 | 0.837 |
COLO 858 | Vemurafenib | 1 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 219.1 | 2 | 0077-0393 | 141.79 | 393.65 | 318 | 69.26 | 0.833 |
COLO 858 | Vemurafenib | 1 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 225.6 | 2 | 0078-0397 | 212.63 | 398.04 | 322 | 65.60 | 0.940 |
COLO 858 | Vemurafenib | 1 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 240.4 | 2 | 0079-0404 | 652.55 | 404.88 | 359 | 70.77 | 0.901 |
COLO 858 | Vemurafenib | 1 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 197.5 | 2 | 0080-0409 | 431.96 | 408.57 | 379 | 72.67 | 0.902 |
COLO 858 | Vemurafenib | 1 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 279.0 | 2 | 0081-0430 | 485.77 | 430.66 | 314 | 68.18 | 0.849 |
COLO 858 | Vemurafenib | 1 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 223.3 | 2 | 0082-0436 | 193.76 | 436.75 | 316 | 68.43 | 0.848 |
COLO 858 | Vemurafenib | 1 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 254.8 | 2 | 0083-0436 | 587.81 | 435.82 | 323 | 69.01 | 0.852 |
COLO 858 | Vemurafenib | 1 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 296.1 | 2 | 0084-0437 | 42.06 | 436.96 | 271 | 61.11 | 0.912 |
COLO 858 | Vemurafenib | 1 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 561.6 | 2 | 0085-0437 | 821.66 | 437.77 | 223 | 56.77 | 0.870 |
COLO 858 | Vemurafenib | 1 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 372.0 | 2 | 0086-0448 | 660.63 | 448.83 | 239 | 58.53 | 0.877 |
COLO 858 | Vemurafenib | 1 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 234.0 | 2 | 0087-0453 | 54.39 | 453.00 | 355 | 70.77 | 0.891 |
COLO 858 | Vemurafenib | 1 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 237.0 | 2 | 0088-0459 | 340.67 | 458.85 | 249 | 61.84 | 0.818 |
COLO 858 | Vemurafenib | 1 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 329.6 | 2 | 0089-0458 | 740.67 | 458.64 | 236 | 59.70 | 0.832 |
COLO 858 | Vemurafenib | 1 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 224.0 | 2 | 0090-0467 | 519.60 | 467.21 | 345 | 69.36 | 0.901 |
COLO 858 | Vemurafenib | 1 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 294.8 | 2 | 0091-0479 | 573.14 | 478.52 | 194 | 66.43 | 0.552 |
COLO 858 | Vemurafenib | 1 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 215.0 | 2 | 0092-0489 | 169.47 | 489.35 | 315 | 70.77 | 0.790 |
COLO 858 | Vemurafenib | 1 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 224.5 | 2 | 0093-0519 | 590.31 | 518.90 | 428 | 82.08 | 0.798 |
COLO 858 | Vemurafenib | 1 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 260.1 | 2 | 0094-0517 | 202.43 | 517.49 | 317 | 67.36 | 0.878 |
COLO 858 | Vemurafenib | 1 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 235.2 | 2 | 0095-0523 | 87.21 | 522.84 | 469 | 81.50 | 0.887 |
COLO 858 | Vemurafenib | 1 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 286.6 | 2 | 0096-0521 | 771.81 | 521.83 | 313 | 68.77 | 0.832 |
COLO 858 | Vemurafenib | 1 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 233.7 | 2 | 0097-0538 | 125.28 | 538.27 | 288 | 62.53 | 0.926 |
COLO 858 | Vemurafenib | 1 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 243.6 | 2 | 0098-0537 | 646.98 | 536.44 | 248 | 62.18 | 0.806 |
COLO 858 | Vemurafenib | 1 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 239.8 | 2 | 0099-0545 | 186.16 | 545.47 | 349 | 70.43 | 0.884 |
COLO 858 | Vemurafenib | 1 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 248.5 | 2 | 0100-0562 | 460.22 | 561.46 | 366 | 74.43 | 0.830 |